Sebastian Giebel

34PUBLICATIONS
135CO-AUTHORS
Haematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 13, 2026
Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities.

|Jul 09, 2026
Trajectories of anxiety and depressive symptoms during hospitalization for hematopoietic stem cell transplantation.

|Mar 06, 2026
Anti-thymocyte globulin (ATG)- or alemtuzumab-based graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic hematopoietic cell transplantation (HCT) for patients 40 years and older with acute lymphoblastic leukemia in first complete remission: a study from the EBMT Acute Leukemia Working Party.

Gesine Bug, Myriam Labopin, Jennifer L Byrne

|Jul 16, 2025
Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT.

Sebastian Giebel, Myriam Labopin, Ryszard Swoboda

|Jul 12, 2025
Gemcitabine and Flurbiprofen Enhance Cytotoxic Effects on Cancer Cell Lines Mediated by Mesenchymal Stem Cells.

Agata Kawulok, Paulina Borzdziłowska, Magdalena Głowala-Kosińska

|Jul 07, 2025
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.

Miguel-Angel Perales, Farrukh T Awan, Ariane Boumendil

Pageof 6

Frequent Collaborators

16 joint publications

Arnon Nagler

16 joint publications

Myriam Labopin

16 joint publications

Mohamad Mohty

14 joint publications

Didier Blaise